This Government Contract opportunity from Department Of Defense was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Regulatory Content Review and Quality Assurance (QA) for SPL
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the independent review and validation of Structured Product Labeling (SPL) content to ensure its accuracy, consistency, and compliance with FDA and government standards. The scope includes detailed verification of clinical pharmacology information, warnings, dosage instructions, and adverse reaction data to uphold regulatory requirements. The subcontract is managed by the Army Medical Resources Acquisition Activity under the Department of Defense and is set to be performed in Frederick, Maryland. The opportunity, titled "Regulatory Content Review and Quality Assurance (QA) for SPL," was posted on May 15, 2026, with a response deadline of June 5, 2026. It falls under the NAICS code 541611, indicating professional, scientific, and technical services. This contract seeks specialized expertise to conduct meticulous quality assurance of medical and regulatory content, supporting compliance efforts vital to public health and safety within the defense medical sector.
General Info
Agency
NAICS
Place of Performance
Frederick, MD, 21702, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
